Author:
Kao D. P.,Kohrt H. E.,Kugler J.
Subject
Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine
Reference5 articles.
1. Effect of renal insufficiency on the pharmacokinetics of sitagliptin, a dipeptidyl peptidase-4 inhibitor;Bergman;Diabetes Care,2007
2. Pharmacokinetics and pharmacodynamics of single doses of sitagliptin, an inhibitor of dipeptidyl peptidase-IV in healthy subjects;Herman;Clin Pharm Therap,2005
3. 3Pharmacology/Toxicology Review and Evaluation-NDA 21-995. Washington, DC: Center for Drug Evaluation and Research, Food and Drug Administration, 2006. Available at http://www.accessdata.fda.gov/scripts/cder/drugsatfda Last accessed 30 April 2008.
4. An algorithm for the operational assessment of adverse drug reactions: I. Background, description, and instructions for use;Kramer;JAMA,1979
5. 5Center for Drug Evaluation and Research. Adverse event reporting system. Center for Drug Evaluation and Research Website. http://www.fda.gov/cder/aers Last accessed 25 October 2007.
Cited by
47 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献